loader
Please Wait
Applying Filters...

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

Technical details about Loviride, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: 147362-57-0, R 89439, R-89439, Chembl37624, 3s1r1lz09h, 2-((2-acetyl-5-methylphenyl)amino)-2-(2,6-dichlorophenyl)acetamide
Molecular Formula
C17H16Cl2N2O2
Molecular Weight
351.2  g/mol
InChI Key
CJPLEFFCVDQQFZ-UHFFFAOYSA-N
FDA UNII
3S1R1LZ09H

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-(2-acetyl-5-methylanilino)-2-(2,6-dichlorophenyl)acetamide
2.1.2 InChI
InChI=1S/C17H16Cl2N2O2/c1-9-6-7-11(10(2)22)14(8-9)21-16(17(20)23)15-12(18)4-3-5-13(15)19/h3-8,16,21H,1-2H3,(H2,20,23)
2.1.3 InChI Key
CJPLEFFCVDQQFZ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=CC(=C(C=C1)C(=O)C)NC(C2=C(C=CC=C2Cl)Cl)C(=O)N
2.2 Other Identifiers
2.2.1 UNII
3S1R1LZ09H
2.3 Synonyms
2.3.1 MeSH Synonyms

1. R 89439

2. R-89439

2.3.2 Depositor-Supplied Synonyms

1. 147362-57-0

2. R 89439

3. R-89439

4. Chembl37624

5. 3s1r1lz09h

6. 2-((2-acetyl-5-methylphenyl)amino)-2-(2,6-dichlorophenyl)acetamide

7. 141030-40-2

8. 2-(2-acetyl-5-methylanilino)-2-(2,6-dichlorophenyl)acetamide

9. Unii-3s1r1lz09h

10. Loviride [usan:inn:ban]

11. Loveride

12. Alpha-apa

13. .alpha.-apa

14. Starbld0009613

15. Loviride [usan]

16. Loviride (usan/inn)

17. Loviride [inn]

18. Loviride [mart.]

19. Loviride [who-dd]

20. Schembl247781

21. Dtxsid60869958

22. (+-)-2-(6-acetyl-m-toluidino)-2-(2,6-dichlorophenyl)acetamide

23. Bdbm50030539

24. Benzeneacetamide, Alpha-((2-acetyl-5-methylphenyl)amino)-2,6-dichloro-

25. Benzeneacetamide, Alpha-((2-acetyl-5-methylphenyl)amino)-2,6-dichloro-, (+-)-

26. Hy-15355

27. Cs-0005982

28. D04786

29. R89439

30. Q6692646

31. 2-(2-acetyl-5-methyl-anilino)-2-(2,6-dichlorophenyl)acetamide

32. (+/-)-2,6-dichloro-.alpha.-[(2-acetyl-5-methylphenyl)amino]benzamide

33. (+/-)-2-(6-acetyl-m-toluidino)-2-(2,6-dichlorophenyl)acetamide

34. 2-(2-acetyl-5-methyl-phenylamino)-2-(2,6-dichloro-phenyl)-acetamide

35. Benzeneacetamide, .alpha.-((2-acetyl-5-methylphenyl)amino)-2,6-dichloro-, (+/-)-

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 351.2 g/mol
Molecular Formula C17H16Cl2N2O2
XLogP34.4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count5
Exact Mass350.0588831 g/mol
Monoisotopic Mass350.0588831 g/mol
Topological Polar Surface Area72.2 Ų
Heavy Atom Count23
Formal Charge0
Complexity436
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antiviral Agents

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)


Reverse Transcriptase Inhibitors

Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. (See all compounds classified as Reverse Transcriptase Inhibitors.)


Post Enquiry
POST ENQUIRY